Specific germline single nucleotide variants in long-term recurrence-free survivors of advanced ovarian cancer
Takashi Mitamura(Sapporo University), Hidemichi Watari(Hokkaido University of Science), Emi Sakurai, Fuyuka Igarashi, Hiroyuki Yamazaki(Hokkaido University), Hiroko Matsumiya(Hokkaido University Hospital), Hiroyuki Kurosu(Hokkaido University), Yosuke Konno(Hokkaido University of Science), Tianyue Zhai(Hokkaido University), Kei Ihira(Hokkaido University), Mahito Takeda(Sapporo University), Daisuke Endo(Gifu University), Noriko Kobayashi(Tokyo Medical University)
Cited by 0
Related Papers
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
|Cancer Research|2016|178
Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
|Journal of Experimental & Clinical Cancer Research|2019|164
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
|Oncotarget|2014|155
The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
|Journal of Translational Medicine|2014|129
MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
|Journal of Experimental & Clinical Cancer Research|2016|123